Systemic inflammation, metabolic syndrome and progressive renal disease. - Wikidata - awgldk - TriplyDB

Systemic inflammation, metabolic syndrome and progressive renal disease.

Systemic inflammation, metabolic syndrome and progressive renal disease.

http://www.wikidata.org/entity/Q43078030

about

Immune dysfunction in uremia—an update Soft drinks consumption and nonalcoholic fatty liver disease Role of the immune system in hypertension: modulation by dietary antioxidants.Obesity and inflammation: the linking mechanism and the complications Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls.Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis.Dietary fats and health: dietary recommendations in the context of scientific evidence Post-ischemic azotemia as a partial 'brake', slowing progressive kidney disease.Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis.The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease.Vasopressin Mediates the Renal Damage Induced by Limited Fructose Rehydration in Recurrently Dehydrated Rats.Effects of acute exercise on markers of inflammation in pediatric chronic kidney disease: a pilot study.

P2860

Q26829076-6B7A0FD8-F7DB-4375-83B0-0D418F653C46 Q28284041-C32C0BC9-F57E-4D38-9FE8-B3F740BD97C7 Q30424339-C6691E45-B7FD-4D2B-82E7-4A1EDF151187 Q33897331-BB650F62-6AFF-43D3-9715-3F6E1B5A3232 Q34069352-F5A6CA99-B140-4E6E-A8AE-6893C97C60CC Q34595173-1BC497EF-17F5-45E1-A17D-2048D56901D0 Q35620974-BC115F58-1F83-400B-8EC8-4E3B63C9C811 Q36295250-10FBDB4D-128D-4EB5-94AC-F3C10B810262 Q36829154-C33C0EC8-C688-4E6B-9426-2BCBA8666EB9 Q36832940-A7EB9651-4C97-4404-8218-38F97C928074 Q36936610-B96E7162-5199-4CD0-B916-66EA032A5D28 Q37417285-8C116D18-A415-4E47-9D7C-5191ACD0B7BD Q37601247-92DA8B84-95BB-4EDD-BB7A-9CAA86E9AE11 Q37903030-A9B1A53F-FEF1-4196-B823-62FCC1136F0F Q38589252-B3257B37-2C28-492D-A95D-4BF667241E63 Q39062964-B8A9D20A-D9EE-4FA0-BF1D-B9C79F822135 Q41036208-89130B7C-C5B4-401A-AA87-7D1EBB024CDD Q53012778-635B394A-2A04-4475-B8C7-B311C4F757FF

P2860

Systemic inflammation, metabolic syndrome and progressive renal disease.

http://www.wikidata.org/entity/Q43078030

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Systemic inflammation, metabolic syndrome and progressive renal disease.

@en

Systemic inflammation, metabolic syndrome and progressive renal disease.

@nl

type

label

Systemic inflammation, metabolic syndrome and progressive renal disease.

@en

Systemic inflammation, metabolic syndrome and progressive renal disease.

@nl

prefLabel

Systemic inflammation, metabolic syndrome and progressive renal disease.

@en

Systemic inflammation, metabolic syndrome and progressive renal disease.

@nl

P1433

Q43078030-3B291772-52D4-4989-BF6B-9B3DCE46F041

P1476

Q43078030-005955AB-D303-40F9-920C-9146D4E5CD43

P2093

Q43078030-2B3FD351-BFBD-44B8-BA83-5ABECEAF0E01

Q43078030-5C760627-A326-498F-BDFC-D671C941CA82

Q43078030-6A9FCDA2-EEE9-4070-8E38-1DB5D91756FB

Q43078030-6AA927F6-1078-4A33-B31A-B36AFCCF636E

Q43078030-87429811-5BD8-4AE8-8446-5AF2C22F31A2

Q43078030-B65E5C57-D6B6-4B41-A950-FBA0BEC05881

Q43078030-FD780EC0-E9D9-4FA2-A5EA-CB9E2791748B

P2860

Q43078030-0D995A49-9B0E-4E41-82F2-872BD9FA6937

Q43078030-0EA8793F-73F3-4CDA-B4D8-AF3CE19FD70F

Q43078030-0FDE9BC5-9A0F-41DD-BBBA-8260FD904AA0

Q43078030-18FFC9B8-7097-4C33-9E01-C01D3BC66459

Q43078030-1E4F0BD1-0677-4652-91E3-A36C5C40104E

Q43078030-20D2718C-A54D-4823-BA59-6AA0EE9CEBB2

Q43078030-26ABBA10-F54B-4E45-86D5-9D6D179CB327

Q43078030-29020DA4-9713-4BD8-8D61-E9E9BC907E6E

Q43078030-29909775-0EF5-4DB9-8E7F-FBB4AC7C635B

Q43078030-2F77F25D-B3A6-4256-A35B-E48E87337077

P304

Q43078030-2D731300-7895-49D7-9686-D5A64EC5352C

P31

Q43078030-6CD573BA-9300-46E6-ADE5-24902A54D4F0

Q43078030-e5e679ca-2dd9-4123-a81d-67ad099d084a

P356

Q43078030-0AEFC34A-8105-4576-8C5E-711073307198

P407

Q43078030-0174F29A-F366-4C6B-8B3B-1EA684AEA29B

P433

Q43078030-839592E8-5A32-4B6F-BC69-57C1E623419B

P478

Q43078030-C73CA574-4E56-4857-A2B7-0A8A6BF0B0A5

P577

Q43078030-22E22F2F-BD1A-44A3-A6B7-230416B824DD

P5875

Q43078030-382E9B3B-6616-4415-92B9-9B0B75B91CB7

P698

Q43078030-2E13BEEC-D256-4458-8D44-00C4142A4B37

P921

Q43078030-2DD89BB7-E8C4-4142-886A-E6864EBD1AE5

P932

Q43078030-A8DA631E-5F86-4C2A-87B2-BFFC95FA6A4F

P356

P1433

Nephrology Dialysis Transplantation

P1476

Systemic inflammation, metabolic syndrome and progressive renal disease.

@en

P2093

Duk-Hee Kang

http://www.w3.org/2001/XMLSchema#string

John Kanellis

http://www.w3.org/2001/XMLSchema#string

Loreto Gesualdo

http://www.w3.org/2001/XMLSchema#string

Pietro Cirillo

http://www.w3.org/2001/XMLSchema#string

Richard J Johnson

http://www.w3.org/2001/XMLSchema#string

Takahiko Nakagawa

http://www.w3.org/2001/XMLSchema#string

Yuri Y Sautin

http://www.w3.org/2001/XMLSchema#string

P2860

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

Adverse effects of dietary fructose

IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Burden of obesity--lessons learnt from Hong Kong Chinese.

End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?

Fructose, weight gain, and the insulin resistance syndrome.

Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.

P304

1384-1387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFP038

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23999184

http://www.w3.org/2001/XMLSchema#string

P698

19208772

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

2721462

http://www.w3.org/2001/XMLSchema#string